Lewis Capaldi tested a newly developed device which aims to ease the symptoms of Tourette’s at the University of Nottingham before a concert.
The West Lothian singer, who went public with his diagnosis in September, was in Nottingham on Friday as part of his ongoing UK tour.
He was pictured at the University of Nottingham as he tested Neopulse, a ‘Tourettes Therapy Device’, which sits on the wrist of the user and aims to reduce tics by intercepting signals to the brain.
Capaldi got in touch with researchers as “he was keen to try it out” after reading about the invention.
The university revealed the singer was “delighted” as the device helped him relax and reduced his shoulder and head tics.
He then proceeded to invite the team behind the device to his concert at the Motorpoint Arena on Friday evening.
Prof Stephen Jackson, who has led the research, said: “The results were remarkable – Lewis stated that the stimulation made him feel calmer and the device clearly suppressed the head and shoulder tics which can be quite painful for him.”
In 2022, Neopulse was tested in a clinical trial involving more than 100 people.
The NHS states that Tourette’s syndrome is a condition that causes a person to make involuntary sounds and movements called tics.
Capaldi opened up about his diagnosis to his fans during an Instagram live in September, and revealed he is learning to live with twitches and the condition itself.
He said that the Tourette’s diagnosis “made a lot of sense”.
Follow STV News on WhatsApp
Scan the QR code on your mobile device for all the latest news from around the country
